重大事件
外國發行人報告
6-K
2026-07-13
文遠知行獲聯交所豁免上市規則，創始人及CTO將股份配發予家族信託
AI 繁中摘要
文遠知行（WeRide Inc.，股份代號：0800）於2026年7月13日提交6-K表格，公告獲香港聯交所授予豁免，毋須嚴格遵守上市規則第8A.18(1)條。該豁免旨在配合兩項股份配發及發行安排：(i) 由創始人、主席兼CEO韓旭博士全資擁有的英屬維京群島公司Xu Han Limited（XHL），將公司B類普通股配發及發行予韓旭博士為保護人、其子女及後代為受益人的家族信託受託人；(ii) 由聯合創始人、執行董事兼CTO李巖博士全資擁有的Humber Partners Limited，將公司A類及B類普通股配發及發行予李巖博士為保護人的家族信託受託人。完成後，XHL由韓旭博士持有80%、其家族信託持有20%；Humber Partners由李巖博士持有80%、其家族信託持有20%。豁免基於韓旭博士及李巖博士各自繼續擔任家族信託保護人，並保留對信託結構內所持B類普通股投票權的獨家控制權。此舉不改變實際控制權，但優化股權持有架構，投資者應注意股權集中度及家族信託安排對公司治理的潛在影響。
展開英文正文
EX-99.1 2 tm2620306d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. WeRide Inc. 文遠知行* (A company controlled through weighted voting rights and incorporated in the Cayman Islands with limited liability) (Stock code: 0800) GRANT OF WAIVER FROM STRICT COMPLIANCE WITH RULE 8A.18(1) OF THE LISTING RULES WeRide Inc. (the “Company”) hereby advises shareholders and other investors that it has applied for, and The Stock Exchange of Hong Kong Limited has granted, a waiver (the “Waiver”) from strict compliance with Rule 8A.18(1) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited to facilitate (i) the allotment and issuance of new shares by Xu Han Limited (“XHL”), a British Virgin Islands company wholly owned by Dr. Tony Xu Han (“Dr. Han”), the founder, chairman of the board, executive director, chief executive officer and a beneficiary of weighted voting rights of the Company (a “WVR Beneficiary”), that holds class B ordinary shares of the Company to the trustee of a family trust where Dr. Han is the protector and his children and descendants are the beneficiaries; and (ii) the allotment and issuance of new shares by Humber Partners Limited (“Humber Partners”), a British Virgin Islands company wholly owned by Dr. Yan Li (“Dr. Li”), the co-founder, executive director, chief technology officer and a WVR Beneficiary of the Company, that holds class A ordinary shares and class B ordinary shares of the Company to the trustee of a family trust where Dr. Li is the protector and his children and descendants are the beneficiaries. Following the aforementioned share allotment and issuance, XHL is owned as to 80% by Dr. Han and as to 20% by the trustee of Dr. Han’s family trust, and Humber Partners is owned as to 80% by Dr. Li and as to 20% by the trustee of Dr. Li’s family trust. The Company applied for the Waiver, and the Waiver was granted, on the bases, among others, that each of Dr. Han and Dr. Li will remain the protector of his family trust and will retain sole control over the voting rights attached to the class B ordinary shares of the Company held within his family trust structure following the aforementioned share allotment and issuance. By Order of the Board WeRide Inc. Dr. Tony Xu Han Chairman of the Board, Executive Director and Chief Executive Officer Hong Kong, July 13, 2026 As of the date of this announcement, the board of directors of the Company comprises Dr. Tony Xu Han and Dr. Yan Li as executive directors, Mr. Ichijo Futakawa and Mr. Jean-François Salles as non-executive directors, and Ms. Huiping Yan, Mr. David Zhang and Dr. Tony Fan-cheong Chan as independent non-executive directors. *For identification purposes only